课题基金 / 基金详情

Development of standard care evaluation of pressure ulcers by the molecular biological approach

Development of standard care evaluation of pressure ulcers by the molecular biological approach
通过分子生物学方法制定压疮标准护理评估
批准号:
17592200
负责人:
KONYA Chizuko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KONYA Chizuko的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在探讨难治性压疮中细胞因子的变化及其与创面愈合过程的关系。我们研究了压疮和伤口变化模式中的细胞因子,以澄清细胞因子在每种状态下的行为。3天和7天后更换护理,测量保留的细胞因子渗出液的水平;白细胞介素l - α和1β (IL-lα, 1β)、碱性成纤维细胞生长因子(bFGF)、血小板源性生长因子- ab (PDGF-AB)、白细胞介素4 (IL-4)、转化生长因子-β1 (TGF-β1)和血管内皮生长因子(VEGF)。每周观察伤口。所有受试者都同意参加这项研究。细胞因子在每次伤口变化时都增加:对于破坏粘附,它是7 / 7 (VEGF在7 - 3天升高);肉芽增加,8 / 8 (bFGF在3天后);上皮化也有80% (bFGF在3天后)。压疮的标准护理评估是根据这些结果制定的。我们的标准护理评价结果为:bFGF阳性预测值70.0%,VEGF阳性预测值66.7%。因此,建议我们的压疮标准护理评估是有效的。
英文摘要
The purpose of this study was investigated the change in cytokines in refractory pressure ulcers and relationship between its changing and wound healing process. We investigated cytokines in pressure ulcers and wound change patterns in order to clarify cytokine behaviour at each status. After three days and seven days changing care measurements were performed of the levels in retained exudate of the cytokines; interleukin lα and 1β (IL-lα, 1β), basic fibroblast growth factor (bFGF), platelet-derived growth factor-AB (PDGF-AB), interleukin-4 (IL-4), transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF). Wounds were observed weekly. All subjects had consented to participate in the study. Cytokines were increased at each wound change: for undermining adhesion, it was six out of seven (elevation in VEGF at seven three days); for increased granulation, eight out of eight (bFGF at after three days); and for epithelialization also eight out of ten (bFGF at after three days). Standard care evaluation of pressure ulcers was developed from these results. The results of our standard care evaluation were as follow: positive predictive value of bFGF 70.0% and positive predictive value of VEGF 66.7%. Therefore, it was suggested that our standard care evaluation of pressure ulcers was effective.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
治療ガイドラインを見据えた褥瘡治療の流れ 難治性褥瘡と看護 ポケットについての新しい知見
基于治疗指南的压疮治疗流程 关于顽固性压疮和护理袋的新知识
DOI: --
发表时间: 2005
期刊: エキスパートナース 21(4)
影响因子: --
作者: [紺家千津子, 真田弘美]
通讯作者: 真田弘美
DOI: --
发表时间: 2005
期刊: Journal of Japanese Society of Pressure Ulcers 7(4)
影响因子: --
作者: [Chizuko Konya, et. al.]
通讯作者: et. al.
DOI: --
发表时间: 2005
期刊: 日本褥瘡学会誌 7(3)
影响因子: --
作者: [紺家 千津子, 他]
通讯作者:
DOI: --
发表时间: 2005
期刊: Journal of Japanese Society of Pressure Ulcers 7(3)
影响因子: --
作者: [Chizuko Konya, et. al.]
通讯作者: et. al.
Improve skin care: Developing a system to prevent skin tears
  • 批准号:
    26463223
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2014
  • 负责人:
    KONYA Chizuko
  • 依托单位:
Developing a self-care education system to prevent peristomal skin disorders
  • 批准号:
    23593270
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2011
  • 负责人:
    KONYA Chizuko
  • 依托单位:
The development of evidence-based nursing for molecular biology : the pressure ulcer with undermining care
  • 批准号:
    19592434
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    KONYA Chizuko
  • 依托单位:
国内基金
海外基金
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
  • 批准号:
    82372328
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    项盈
  • 依托单位:
自身免疫性T细胞的抗原决定簇在抗肾小球基底膜病发病中的启动机制
  • 批准号:
    81170645
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    崔昭
  • 依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data